Stay Updated
Press Releases
TODAY: Cancer Patient David Mitchell Addresses National Academy of Medicine Conference
WASHINGTON, DC — Today at 10:30 AM, David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs, will deliver remarks at a National Academy of Medicine workshop designed to explore strategies and policies that ensure drugs funded with taxpayer investment remain accessible and affordable to patients. Read the full text of his […]
Press Releases
Celgene To Pay $55 Million To Settle Class Action Lawsuit
WASHINGTON, DC — Celgene Corporation agreed to pay $55 million to settle a class action lawsuit over its efforts to block generic competition in order to repeatedly raise prices on two key cancer drugs. Celgene’s practices were alleged to have cost cancer patients and taxpayers millions of dollars. David Mitchell, who is in continuous treatment for […]
Press Releases
MEDIA ADVISORY: Patients Implore Congress to Stand Up To Big Pharma
WASHINGTON, DC — On Friday, July 26, patients will testify before Congress on the destructive financial impact of rising prescription drug prices. The hearing before the House Committee on Oversight and Reform called “The Patient Perspective: The Devastating Impacts of Skyrocketing Drug Prices on American Families,” will take place at 9:30 a.m. on July 26. Watch a […]
Press Releases
WASHINGTON, DC — On Thursday, David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs, will deliver remarks at an NAM workshop designed to explore strategies and policies that ensure drugs funded with taxpayer investment remain accessible and affordable to patients. The workshop, “Strategies and Policies to Ensure Affordable Access to Innovative Drugs that […]
Press Releases
Taxpayer-Funded Drugs and a Pricing Crisis: A Cure for Sickle Cell
WASHINGTON, DC — Taxpayers invested hundreds of millions of dollars into a new cure for sickle cell disease, a devastating illness that impacts 1 in 365 African Americans, according to a new report from Patients For Affordable Drugs. In the report, “Taxpayer-funded Drugs and a Pricing Crisis,” the patient advocacy organization calls on the National […]
Press Releases
10 Drug Corporations Drive One-Third of Taxpayer Spending in Medicare Part D
WASHINGTON, DC — Negotiating for the 250 most-expensive drugs in Medicare Part D would address nearly 80 percent of all spending in the program, according to an updated analysis by Patients For Affordable Drugs. The analysis, using data from CMS’ Medicare Part D Drug Spending Dashboard, found the top 250 drugs cost the program $118 Billion, […]
Press Releases
Vertex is pricing life-saving medicines out of reach.
To: Vertex Pharmaceuticals CEO Jeffrey Leiden We are members of cystic fibrosis, investment, and religious communities, and we agree that Vertex Pharmaceuticals, a Boston-based drug corporation, has priced life-saving drugs out of reach. It’s unfair. It’s unjust. And it must change. Cystic fibrosis is a rare genetic disease that impacts 70,000 to 100,000 people worldwide. […]
Press Releases
CHART PACK: New Analysis Shows Lion’s Share Of Part D Spending is For a Small Percentage of Drugs
WASHINGTON, DC — As Congress moves toward consideration of legislation to enable direct Medicare drug price negotiation, Patients For Affordable Drugs conducted an analysis to determine where the greatest savings could be achieved. The analysis, using data from CMS’ Medicare Part D Drug Spending Dashboard, shows that less than 1 percent of drugs accounts for […]